Over 20 Total Lots Up For Auction at One Location - TX Cleansweep 06/25

Apollo Hospital in New Delhi initiates first non-invasive ZAP-X brain tumor treatment in South Asia

Press releases may be edited for formatting or style | March 08, 2024 Rad Oncology Operating Room
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Apollo Hospital in New Delhi, India, completed its first patient treatment using the new ZAP-X® Gyroscopic Radiosurgery® platform. Following the recent announcement of a strategic partnership and multi-system ZAP-X system order, this first patient treatment marks a significant milestone in the partnership between ZAP Surgical and Apollo Hospitals Enterprise Ltd. As part of the collaboration, the ZAP-X site in New Delhi will also become the regional reference site for customer training and site visits.

“We’re incredibly excited to introduce our first of several ZAP-X systems to the Apollo network of hospitals,” said Dr. Prathap Reddy, Founder and Chairman of Apollo Hospitals Enterprise Ltd. “It perfectly complements our mission to improve patient outcomes and advance the standard of brain tumor treatments.”

Stereotactic radiosurgery (SRS) provides a non-invasive option for treating many primary and metastatic brain tumors, as well as other conditions of the head and neck. Notably, SRS has shown equivalent to superior outcomes compared to traditional surgeries. Involving only one to five brief outpatient visits, SRS often allows patients to resume normal activities on the same day as the procedure.

Employing a ground-breaking design, the recently introduced ZAP-X system utilizes distinctive gyroscopic mobility to guide radiosurgical beams from thousands of potential angles to precisely focus high-dose radiation on the targeted tumor. This pioneering approach aims to maximally safeguard healthy brain tissue and preserve patient cognitive function.

The first patient, a 66-year-old male, was treated for a metastatic tumor in the pineal gland, a tiny endocrine gland in the middle of the brain that helps regulate the body's sleep-wake cycle. Such tumors may cause problems by pressing against other parts of the brain, with symptoms including headaches, nausea and vomiting, vision changes as well as balance or coordination problems.

“Pineal tumors are extremely difficult to remove with open surgery as they are anatomically located within the center of the brain. Accordingly, the non-invasive nature of ZAP-X makes it an ideal treatment for this patient - as well as millions of other patients each year who develop brain tumors in other regions of the brain,” said Dr. John R. Adler, CEO of ZAP Surgical and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. “ZAP is honored to support Apollo Hospitals in expanding global access to this potentially life-saving treatment.”

You Must Be Logged In To Post A Comment